The Latest

Whether you're a patient, clinician, retailer or researcher, come with us as we work to bring quality, accessible cannabis care (and data) to all.

Featured

News

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

March 11, 2026

EO Team

EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.

News

EO Data & Methodology: November 2025 Update

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from real people using cannabis to manage symptoms such as pain, sleep disturbance, anxiety, and nausea/vomiting, under the guidance of our clinical protocols.

News

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also reported low rates of use-limiting side effects with further reductions after receiving updated recommended product and/or dosing guidance via EO Care’s digital care platform.

News

Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective

Recently, the Department of Health and Human Services recommended that cannabis be reclassified from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. In a PM360 article Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective,

News

Insight for Employers: Employees Are More Likely to Apply for Jobs Offering Cannabis Benefits

As more states legalize the use of cannabis, it can be challenging for employers to keep up and find reliable information. A recent Benefits Pro article, Employees are more likely to apply for jobs that offer cannabis benefits, shares findings from an EO Care ...

News

Imerman Angels & EO Care: A Partnership to Provide Clinically Guided Cannabis Care and Advice to Members

1 in 2 people will get cancer in their lifetime, and 40% of cancer patients use cannabis for treatment of symptoms. But clinical guidance for cannabis is difficult to find. That’s why Imerman Angels is partnering with EO Care — the first clinically guided cannabis health and wellness solution for employers, payers, and associations — to provide cannabis care and advice to members. ImermanAngels.org visitors will be able to access educational content including whether cannabis is right for them, how to optimize use, and even how to reduce use.

News

Get to Know Ethan Zohn, the Ultimate “Survivor”

Ethan Zohn truly embodies the word “survivor.” In 2001, he won Survivor Africa, the third season of the popular reality TV show — and later became a two-time survivor of a rare blood cancer. At the age of 35 and in the prime of his life, this fit, former professional soccer player was diagnosed with CD20+ Hodgkin’s Lymphoma. Over several years, Ethan endured aggressive treatment including two stem cell transplants.

News

Twist Out Cancer Turns to EO for Clinically Guided Cannabis Care and Advice for Their Community of Cancer Survivors and Caregivers

40% of cancer patients use cannabis to help the treatment of symptoms. But many are going it alone without clinical guidance, which can be ineffective and even unsafe. That’s why non-profit cancer survivor and caregiver support community Twist Out Cancer is partnering with EO Care...

News

Marijuana as a Schedule III Drug: What Insurers and Employers Need to Know

EBN Talks with Bill Van Faasen, former chairman and CEO of Blue Cross Blue Shield Massachusetts and EO Care board member

News

Upcoming Webinar - Cannabis Use & Employee Health: Guiding Employers on Chronic Illness and Legal Implications

On August 30, 2023, after a scientific/clinical review the US Department of Health and Human Services (HHS) acknowledged that cannabis has medicinal uses and recommended rescheduling cannabis to a Class 3 drug

News

Unlocking Safe and Informed Cannabis Use in the Workplace: What Every Employer Needs to Know

In a recent Benefits Pro article What employers need to know about "guided use" of cannabis by Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology, and the Program Director of Cannabis Medicine for the Science and Business Master’s Program...

News

Navigating Cancer Care and Cannabis Use: Transforming Workplace Support

As employers continue to navigate the evolving dynamics of employee cannabis use, Human Resource Executive spoke with Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology...

News

Navigating Employee Cannabis Use in the Workplace

eo Care in partnership with HR.com hosted an Employee Cannabis Use – Prevalence, Implications & Solutions webinar for HR professionals where we reviewed the prevalence of cannabis being at an all-time high, the risks of unguided use, and the benefits of employers offering health & wellness support in the form of clinically guided essential cannabis guidance for critical illnesses such as cancer, as well as symptom support, such as pain management, anxiety, and sleeplessness; resulting in improved workforce health, job satisfaction, and increased productivity.

Research

(Part 1) Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence

The lack of pain relief combined with the risk of dangerous side effects, including death, has led to a need for alternative options to help treat chronic pain. Recently, there has been growing interest in the possibility that cannabis may be useful in combination or as a substitute for opioids in people with chronic pain.

Research

(Part 2) Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence

Despite conflicting evidence, for many patients with chronic pain, the risk of using opioids may be greater than the benefits, especially over long periods of time. It is important that patients wishing to understand the potential benefits and risks of using cannabis in addition to opioids discuss this with their health care provider prior to use.

The Latest

Featured

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

EO Data & Methodology: November 2025 Update

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective

Insight for Employers: Employees Are More Likely to Apply for Jobs Offering Cannabis Benefits

Imerman Angels & EO Care: A Partnership to Provide Clinically Guided Cannabis Care and Advice to Members

Get to Know Ethan Zohn, the Ultimate “Survivor”

Twist Out Cancer Turns to EO for Clinically Guided Cannabis Care and Advice for Their Community of Cancer Survivors and Caregivers

Marijuana as a Schedule III Drug: What Insurers and Employers Need to Know

Upcoming Webinar - Cannabis Use & Employee Health: Guiding Employers on Chronic Illness and Legal Implications

Unlocking Safe and Informed Cannabis Use in the Workplace: What Every Employer Needs to Know

Navigating Cancer Care and Cannabis Use: Transforming Workplace Support

Navigating Employee Cannabis Use in the Workplace

(Part 1) Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence

(Part 2) Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence

EO in Your Inbox